Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2001 1
2002 3
2003 1
2004 2
2005 4
2006 7
2008 15
2009 11
2010 8
2011 12
2012 8
2013 13
2014 13
2015 11
2016 18
2017 18
2018 30
2019 37
2020 43
Text availability
Article attribute
Article type
Publication date

Search Results

242 results
Results by year
Filters applied: . Clear all
Page 1
Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4.
Qin S, Xu L, Yi M, Yu S, Wu K, Luo S. Qin S, et al. Among authors: yi m. Mol Cancer. 2019 Nov 6;18(1):155. doi: 10.1186/s12943-019-1091-2. Mol Cancer. 2019. PMID: 31690319 Free PMC article. Review.
Biomarkers for predicting efficacy of PD-1/PD-L1 inhibitors.
Yi M, Jiao D, Xu H, Liu Q, Zhao W, Han X, Wu K. Yi M, et al. Mol Cancer. 2018 Aug 23;17(1):129. doi: 10.1186/s12943-018-0864-3. Mol Cancer. 2018. PMID: 30139382 Free PMC article. Review.
Organoid technology and applications in cancer research.
Xu H, Lyu X, Yi M, Zhao W, Song Y, Wu K. Xu H, et al. Among authors: yi m. J Hematol Oncol. 2018 Sep 15;11(1):116. doi: 10.1186/s13045-018-0662-9. J Hematol Oncol. 2018. PMID: 30219074 Free PMC article. Review.
Advances and perspectives of PARP inhibitors.
Yi M, Dong B, Qin S, Chu Q, Wu K, Luo S. Yi M, et al. Exp Hematol Oncol. 2019 Nov 11;8:29. doi: 10.1186/s40164-019-0154-9. eCollection 2019. Exp Hematol Oncol. 2019. PMID: 31737426 Free PMC article. Review.
The role of neoantigen in immune checkpoint blockade therapy.
Yi M, Qin S, Zhao W, Yu S, Chu Q, Wu K. Yi M, et al. Exp Hematol Oncol. 2018 Nov 16;7:28. doi: 10.1186/s40164-018-0120-y. eCollection 2018. Exp Hematol Oncol. 2018. PMID: 30473928 Free PMC article. Review.
Next generation chimeric antigen receptor T cells: safety strategies to overcome toxicity.
Yu S, Yi M, Qin S, Wu K. Yu S, et al. Among authors: yi m. Mol Cancer. 2019 Aug 20;18(1):125. doi: 10.1186/s12943-019-1057-4. Mol Cancer. 2019. PMID: 31429760 Free PMC article. Review.
Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment.
Yi M, Jiao D, Qin S, Chu Q, Wu K, Li A. Yi M, et al. Mol Cancer. 2019 Mar 30;18(1):60. doi: 10.1186/s12943-019-0974-6. Mol Cancer. 2019. PMID: 30925919 Free PMC article. Review.
Gut microbiome modulates efficacy of immune checkpoint inhibitors.
Yi M, Yu S, Qin S, Liu Q, Xu H, Zhao W, Chu Q, Wu K. Yi M, et al. J Hematol Oncol. 2018 Mar 27;11(1):47. doi: 10.1186/s13045-018-0592-6. J Hematol Oncol. 2018. PMID: 29580257 Free PMC article. Review.
Activating cGAS-STING pathway for the optimal effect of cancer immunotherapy.
Li A, Yi M, Qin S, Song Y, Chu Q, Wu K. Li A, et al. Among authors: yi m. J Hematol Oncol. 2019 Apr 1;12(1):35. doi: 10.1186/s13045-019-0721-x. J Hematol Oncol. 2019. PMID: 30935414 Free PMC article. Review.
Differential Effector Engagement by Oncogenic KRAS.
Yuan TL, Amzallag A, Bagni R, Yi M, Afghani S, Burgan W, Fer N, Strathern LA, Powell K, Smith B, Waters AM, Drubin D, Thomson T, Liao R, Greninger P, Stein GT, Murchie E, Cortez E, Egan RK, Procter L, Bess M, Cheng KT, Lee CS, Lee LC, Fellmann C, Stephens R, Luo J, Lowe SW, Benes CH, McCormick F. Yuan TL, et al. Among authors: yi m. Cell Rep. 2018 Feb 13;22(7):1889-1902. doi: 10.1016/j.celrep.2018.01.051. Cell Rep. 2018. PMID: 29444439 Free PMC article.
242 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback